TY - JOUR
T1 - Impact of Electronic Point-of-Care Prompts on Human Papillomavirus Vaccine Uptake in Retail Clinics
AU - Meyer, Amanda F.
AU - Borkovskiy, Nicole L.
AU - Brickley, Jennifer L.
AU - Chaudhry, Rajeev
AU - Franqueira, Andrew
AU - Furst, Joseph W.
AU - Hinsch, Donna M.
AU - McDonah, Margaret R.
AU - Myers, Jane F.
AU - Petersen, Randi E.
AU - Finney Rutten, Lila J.
AU - Wilson, Patrick M.
AU - Jacobson, Robert M.
N1 - Funding Information:
We thank all nurse practitioners and nurses at the retail clinics for their help with the intervention and data collection. Thank you to Alicia Meek, Mayo Clinic research coordinator, with guidance in IRB process and with data entry. A thank-you to Dr. Maya Kessler, Primary Care Internal Medicine, Mayo Clinic, for providing general oversight during the intervention development and study implementation. No compensation was provided for these contributions beyond usual salary., The Mayo Clinic Department of Family Medicine funded this study. The funding strictly gave protected research time to complete study and had no role in the design and conduct of the study; analysis and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Mayo Clinic IRB number 16-009635., Amanda Meyer had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors were responsible for study concept and design; acquisition, analysis, or interpretation of data; and manuscript revisions. Ms. Meyer was responsible for drafting of the manuscript, obtaining funding, and study supervision. Mr. Wilson was responsible for statistical analysis. All authors read and approved the final version of the submitted manuscript., Dr. Jacobson reported being a member of two Safety Review Committees for two studies funded by Merck that concern HPV vaccines—one is a post-licensure safety study of Gardasil in males and the other is a post-licensure safety study of Gardasil®9 in both sexes. He is also on a Data Monitoring Committee for a series of prelicensure studies of an experimental 15-valent pneumococcal conjugate vaccine. This is also funded by Merck. No other financial disclosures were reported from authors.
Funding Information:
Dr. Jacobson reported being a member of two Safety Review Committees for two studies funded by Merck that concern HPV vaccines—one is a post-licensure safety study of Gardasil in males and the other is a post-licensure safety study of Gardasil®9 in both sexes. He is also on a Data Monitoring Committee for a series of prelicensure studies of an experimental 15-valent pneumococcal conjugate vaccine. This is also funded by Merck. No other financial disclosures were reported from authors.
Publisher Copyright:
© 2018
PY - 2018/12
Y1 - 2018/12
N2 - Introduction: Human papillomavirus (HPV) vaccination rates nationally are low. This study determined if an electronic point-of-care prompt in the retail clinic setting increases HPV vaccination rates among an eligible population. Study design: An interrupted time series assessed change in weekly HPV vaccination rates with the introduction of an electronic point-of-care prompt and rate change in post-intervention period. Setting/participants: The study sites were two similar retail care clinics in Rochester, Minnesota. Participants were patients who presented to the retail clinics setting between the ages of 9 and 26 years from September 12, 2016, to September 30, 2017. Intervention: HPV vaccine (nonavalent) was made available at both retail clinics. Staff completed a 2-hour lecture on HPV vaccine and one-on-one training for use of the prompt. Pre- and post-intervention rates of HPV vaccination after initiation of electronic point-of-care prompt were measured. A satisfaction survey was given to all patients or parents/guardians between the ages of 9 and 26 years regardless of HPV vaccine status. Main outcome measures: HPV vaccination rates per week before and after the introduction of the electronic point-of-care prompt along with satisfaction with HPV vaccine availability and the point-of-care prompt in the retail clinic setting. Data analysis was completed January 2018. Results: The point-of-care prompt increased the median weekly HPV vaccination rate by 8.6 per 100 patient visits (95% CI=5.8, 11.5, p<0.001). Patients thought it was convenient having HPV vaccine available and helpful to be reminded of the need for HPV vaccine. Conclusions: This study demonstrates a significant increase of HPV vaccine rates in the retail clinic setting with use of a point-of-care prompt.
AB - Introduction: Human papillomavirus (HPV) vaccination rates nationally are low. This study determined if an electronic point-of-care prompt in the retail clinic setting increases HPV vaccination rates among an eligible population. Study design: An interrupted time series assessed change in weekly HPV vaccination rates with the introduction of an electronic point-of-care prompt and rate change in post-intervention period. Setting/participants: The study sites were two similar retail care clinics in Rochester, Minnesota. Participants were patients who presented to the retail clinics setting between the ages of 9 and 26 years from September 12, 2016, to September 30, 2017. Intervention: HPV vaccine (nonavalent) was made available at both retail clinics. Staff completed a 2-hour lecture on HPV vaccine and one-on-one training for use of the prompt. Pre- and post-intervention rates of HPV vaccination after initiation of electronic point-of-care prompt were measured. A satisfaction survey was given to all patients or parents/guardians between the ages of 9 and 26 years regardless of HPV vaccine status. Main outcome measures: HPV vaccination rates per week before and after the introduction of the electronic point-of-care prompt along with satisfaction with HPV vaccine availability and the point-of-care prompt in the retail clinic setting. Data analysis was completed January 2018. Results: The point-of-care prompt increased the median weekly HPV vaccination rate by 8.6 per 100 patient visits (95% CI=5.8, 11.5, p<0.001). Patients thought it was convenient having HPV vaccine available and helpful to be reminded of the need for HPV vaccine. Conclusions: This study demonstrates a significant increase of HPV vaccine rates in the retail clinic setting with use of a point-of-care prompt.
UR - http://www.scopus.com/inward/record.url?scp=85055053677&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055053677&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2018.06.027
DO - 10.1016/j.amepre.2018.06.027
M3 - Article
C2 - 30344033
AN - SCOPUS:85055053677
SN - 0749-3797
VL - 55
SP - 822
EP - 829
JO - American Journal of Preventive Medicine
JF - American Journal of Preventive Medicine
IS - 6
ER -